Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
Hiba Dagher(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Shahnoor Ali(The University of Texas MD Anderson Cancer Center), Rita Deeba(The University of Texas MD Anderson Cancer Center), Anne‐Marie Chaftari(The University of Texas MD Anderson Cancer Center), Ying Jiang(The University of Texas MD Anderson Cancer Center), Shivan Shah(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center)
Cited by 26
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752
Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant <i>Staphylococcus</i> Bacteremic Isolates Embedded in Biofilm
|Antimicrobial Agents and Chemotherapy|2007|347